Suppresses activation of platelets. Induces endothelial injury. Constricts isolated coronary arteries. Inhibits prostacyclin synthase.
Product Details
| Alternative Name: | 13(S)-HPODE |
| |
| MW: | 312.5 |
| |
| CAS: | 33964-75-9 |
| |
| Concentration: | 50µg/ml for 50ug size. 1mg/ml for 1mg size. |
| |
| Formulation: | Oil dissolved in ethanol. |
| |
| Purity: | ≥98% |
| |
| Shipping: | Shipped on Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Use/Stability: | Open ampule and aliquot into suitable tubes or vials. Store at -80°C or colder. For experiments with cells or tissues, aliquots of ethanol solutions may be added directly to aqueous media. For HPLC, aliquots of ethanol solutions should be evaporated to dryness under a stream of nitrogen and HPLC mobile phase added to the desired concentration. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Rat uterine progesterone receptor analyzed by [3H]R5020 photoaffinity labeling: evidence that the A and B subunits are not equimolar: J. Z. Sun, et al.; Endocrinology
15, 1449 (1987),
Abstract;
Experimental myocardial infarction: effects of a lipid peroxide, 13-hydroperoxy linoleic acid on coronary circulation in rats: M. Mizukami, et al.; Arzneimittelforschung
5, 569 (1984),
Abstract;
Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes: J. A. Salmon, et al.; Biochim. Biophys. Acta.
523, 250 (1978),
Abstract;
